Redirect Notice
The previous page is sending you to
https://www.researchgate.net/figure/MACE-by-baseline-CV-risk-profile-in-all-patients-receiving-tofacitinib-in-the-PsO-cohort_fig4_368340065
.
If you do not want to visit that page, you can
return to the previous page
.